DOJ Secures Deal to Halt Hormone Treatments for Minors at Connecticut Hospital

The Department of Justice disclosed a settlement with Connecticut Children’s Medical Center that ends the facility’s use of gender-transition drugs for patients under the age of 18. As part of the deal, the hospital will pay a monetary penalty and earmark an extra $500,000 for medical care aimed at individuals harmed by the treatments. DOJ investigators said the resolution stems from an ongoing inquiry into potential breaches of federal law concerning such drugs and related surgeries for minors.

Associate Attorney General Stanley Woodward emphasized the government’s commitment to protecting children, while Assistant Attorney General Brett Shumate noted the pattern of similar agreements with Texas Children’s Hospital and the Cleveland Clinic. Although the center rejected the accusations, it confirmed the settlement and stressed that patient privacy remained protected throughout the process. The agreement allows the institution to continue its broader mission of improving child health.